CorMedix Inc.
CRMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $476,860 | $191,395 | $169,380 | $171,142 |
| - Cash | $40,651 | $43,643 | $43,375 | $53,317 |
| + Debt | $517 | $668 | $802 | $924 |
| Enterprise Value | $436,726 | $148,420 | $126,808 | $118,748 |
| Revenue | $43,472 | $0 | $65 | $191 |
| % Growth | – | -100% | -65.7% | – |
| Gross Profit | $40,282 | -$206 | $62 | $42 |
| % Margin | 92.7% | – | 94.3% | 22% |
| EBITDA | -$18,979 | -$46,234 | -$30,052 | -$29,376 |
| % Margin | -43.7% | – | -45,945.1% | -15,385.1% |
| Net Income | -$17,930 | -$46,339 | -$29,702 | -$28,210 |
| % Margin | -41.2% | – | -45,409.9% | -14,774.7% |
| EPS Diluted | -0.3 | -0.91 | -0.74 | -0.75 |
| % Growth | 67% | -23% | 1.3% | – |
| Operating Cash Flow | -$50,615 | -$38,409 | -$24,357 | -$21,155 |
| Capital Expenditures | -$116 | -$327 | -$219 | -$1,425 |
| Free Cash Flow | -$50,730 | -$38,737 | -$24,576 | -$22,581 |